Search the Appendices of Resolution CM/Res(2018)1
2559 found
INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
INTERFERON ALFA-2A | L03AB04 | RO | I | 1487 | 03-01-2001 | VALID | ||
INTERFERON ALFA-2B | L03AB05 | RO | I | 5871 | VALID | |||
INTERFERON BETA-1A | L03AB07 | RO | I | 2158 | 15-08-2001 | VALID | ||
INTERFERON BETA-1B | L03AB08 | RO | I | 2273 | 25-10-2001 | VALID | ||
INTERFERON ALFACON-1 | L03AB09 | RO | I | 629 | 30-06-2000 | VALID | ||
PEGINTERFERON ALFA-2B | L03AB10 | RO | I | 2869 | 27-09-2002 | VALID | ||
PEGINTERFERON ALFA-2A | L03AB11 | RO | I | 2820 | 04-09-2002 | VALID | ||
ROPEGINTERFERON ALFA-2B | L03AB15 | RO | I | VALID | ||||
ALDESLEUKIN | L03AC01 | RO | Not authorised | VALID | ||||
LENTINAN | L03AX01 | RO | Not authorised | VALID | ||||
BCG VACCINE | L03AX03 | RO | I | 190 | VALID | |||
TASONERMIN | L03AX11 | RO | I | None | VALID | |||
GLATIRAMER ACETATE | L03AX13 | RO | I | 7077 | 08-05-1998 | VALID | ||
HISTAMINE DIHYDROCHLORIDE | L03AX14 | RO | I | None | VALID | |||
MIFAMURTIDE | L03AX15 | RO | I | None | VALID | |||
PLERIXAFOR | L03AX16 | RO | I | None | VALID | |||
SIPULEUCEL-T | L03AX17 | RO | I | None | VALID | |||
MYCOPHENOLIC ACID | L04AA06 | RO | I | 2623 | 10-05-2002 | VALID | ||
ABATACEPT | L04AA24 | RO | I | 13-07-2018 | VALID | |||
BELATACEPT | L04AA28 | RO | I | None | VALID | |||
CLADRIBINE | L04AA40 | RO | I | VALID | ||||
IMLIFIDASE | L04AA41 | RO | I | 05-10-2020 | EMEA/H/C/004849 | 25-08-2020 | VALID | |
EFGARTIGIMOD ALFA | L04AA58 | RO | I | 18-11-2022 | EMEA/H/C/005849 | 10-08-2022 | VALID | |
ETANERCEPT | L04AB01 | RO | I | 1333 | 13-12-2000 | VALID | ||
INFLIXIMAB | L04AB02 | RO | I | 12-11-2018 | 571 | 02-05-2000 | VALID | |
ADALIMUMAB | L04AB04 | RO | I | None | VALID | |||
CERTOLIZUMAB PEGOL | L04AB05 | RO | I | None | VALID | |||
GOLIMUMAB | L04AB06 | RO | I | None | VALID | |||
DACLIZUMAB | L04AC01 | RO | Not authorised | 13-11-2018 | VALID | |||
BASILIXIMAB | L04AC02 | RO | I | 107 | 03-06-1999 | VALID | ||
ANAKINRA | L04AC03 | RO | I | None | VALID | |||
USTEKINUMAB | L04AC05 | RO | I | None | VALID | |||
TOCILIZUMAB | L04AC07 | RO | I | None | VALID | |||
SECUKINUMAB | L04AC10 | RO | I | None | VALID | |||
SILTUXIMAB | L04AC11 | RO | I | None | VALID | |||
IXEKIZUMAB | L04AC13 | RO | I | 09-11-2016 | EMEA/H/C/003943 | 25-04-2016 | VALID | |
GUSELKUMAB | L04AC16 | RO | Not authorised | 04-05-2018 | VALID | |||
TILDRAKIZUMAB | L04AC17 | RO | Not authorised | 12-11-2018 | VALID | |||
SATRALIZUMAB | L04AC19 | RO | I | 06-12-2021 | EMEA/H/C/004788 | 24-06-2021 | VALID | |
BIMEKIZUMAB | L04AC21 | RO | I | 06-12-2021 | EMEA/H/C/005316 | 20-08-2021 | VALID | |
SPESOLIMAB | L04AC22 | RO | I | 03-10-2023 | EMEA/H/C/005874 | 09-12-2022 | VALID | |
MIRIKIZUMAB | L04AC24 | RO | I | 15-11-2023 | EMEA/H/C/005122 | 26-05-2023 | VALID | |
CICLOSPORIN | L04AD01 | RO | I | 3715 | 21-08-2003 | VALID | ||
TACROLIMUS | L04AD02 | RO | I | 2458 | 05-02-2002 | VALID | ||
VOCLOSPORIN | L04AD03 | RO | POM | 21-11-2023 | EMEA/H/C/005256 | 15-09-2022 | VALID | |
FINGOLIMOD | L04AE01 | RO | I | 07-09-2020 | VALID | |||
OZANIMOD | L04AE02 | RO | I | 05-10-2020 | EMEA/H/C/004835 | 20-05-2020 | VALID | |
SIPONIMOD | L04AE03 | RO | I | VALID | ||||
PONESIMOD | L04AE04 | RO | I | 06-12-2021 | EMEA/H/C/005163 | 19-05-2021 | VALID | |
ETRASIMOD | L04AE05 | RO | I | 14-05-2024 | EMEA/H/C/006007 | 16-02-2024 | VALID |